: Surged over 7% recently due to the Organon acquisition ; remains a top pick for its expanding global specialty generic portfolio.
: Recommended as a "Buy" in the ₹2,324–₹2,325 range, with a target of ₹2,470 , following a bullish breakout on daily charts. indian shares to buy now
The following stocks have been highlighted by leading brokerages like Mirae Asset ShareKhan , Motilal Oswal , and Univest for their current momentum and growth potential: : Surged over 7% recently due to the
: A top weekly pick with a 14% upside target (₹240) , supported by projected 8–10% domestic demand growth through FY30. with a target of ₹2
: Noted for a record order book of ₹24.2 billion , offering high revenue visibility despite regional geopolitical tensions.